m6A Target Gene Information
General Information of the m6A Target Gene (ID: M6ATAR00664)
Full List of m6A Methylation Regulator of This Target Gene and Corresponding Disease/Drug Response(s)
BMI1
can be regulated by the following regulator(s), and cause disease/drug response(s). You can browse detail information of regulator(s) or disease/drug response(s).
Browse Regulator
Browse Disease
Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2BP1) [READER]
Representative RNA-seq result indicating the expression of this target gene regulated by IGF2BP1 | ||
Cell Line | PANC-1 cell line | Homo sapiens |
Treatment: siIGF2BP1 PANC-1 cells
Control: siControl PANC-1 cells
|
GSE161087 | |
Regulation |
|
logFC: -6.85E-01 p-value: 1.16E-03 |
More Results | Click to View More RNA-seq Results |
In total 1 item(s) under this regulator | ||||
Experiment 1 Reporting the m6A Methylation Regulator of This Target Gene | [1] | |||
Response Summary | METTL3 promotes Polycomb complex protein BMI-1 (BMI1) translation in OSCC under the cooperation with m6A reader IGF2BP1. And the study revealed that METTL3 promotes OSCC proliferation and metastasis through BMI1 m6A methylation. | |||
Target Regulation | Up regulation | |||
Responsed Disease | Oral squamous cell carcinoma | ICD-11: 2B6E.0 | ||
In-vitro Model | UM1 | Tongue squamous cell carcinoma | Homo sapiens | CVCL_VH00 |
SCC-9 | Tongue squamous cell carcinoma | Homo sapiens | CVCL_1685 | |
SCC-25 | Tongue squamous cell carcinoma | Homo sapiens | CVCL_1682 | |
SCC-15 | Tongue squamous cell carcinoma | Homo sapiens | CVCL_1681 | |
HSC-3 | Tongue squamous cell carcinoma | Homo sapiens | CVCL_1288 | |
HOK | Normal | Hexagrammos otakii | CVCL_YE19 | |
In-vivo Model | To construct the subcutaneous tumorigenesis model, the cells were suspended in 100 uL of PBS and Matrigel matrix (BD Biosciences, USA) (1:1) and injected into the right flanks of 6-week-old female BALB/c nude mice.To construct the lymph node metastasis model, we injected 1 × 105/50 uL stably infected SCC9 cells into the left hind footpads of BALB/c mice. | |||
Methyltransferase-like 3 (METTL3) [WRITER]
Representative RNA-seq result indicating the expression of this target gene regulated by METTL3 | ||
Cell Line | Pancreatic islets | Mus musculus |
Treatment: Mettl3 knockout mice
Control: Mettl3 flox/flox mice
|
GSE155612 | |
Regulation |
|
logFC: 5.95E-01 p-value: 1.91E-03 |
More Results | Click to View More RNA-seq Results |
In total 1 item(s) under this regulator | ||||
Experiment 1 Reporting the m6A Methylation Regulator of This Target Gene | [1] | |||
Response Summary | METTL3 promotes Polycomb complex protein BMI-1 (BMI1) translation in OSCC under the cooperation with m6A reader IGF2BP1. And the study revealed that METTL3 promotes OSCC proliferation and metastasis through BMI1 m6A methylation. | |||
Target Regulation | Up regulation | |||
Responsed Disease | Oral squamous cell carcinoma | ICD-11: 2B6E.0 | ||
In-vitro Model | UM1 | Tongue squamous cell carcinoma | Homo sapiens | CVCL_VH00 |
SCC-9 | Tongue squamous cell carcinoma | Homo sapiens | CVCL_1685 | |
SCC-25 | Tongue squamous cell carcinoma | Homo sapiens | CVCL_1682 | |
SCC-15 | Tongue squamous cell carcinoma | Homo sapiens | CVCL_1681 | |
HSC-3 | Tongue squamous cell carcinoma | Homo sapiens | CVCL_1288 | |
HOK | Normal | Hexagrammos otakii | CVCL_YE19 | |
In-vivo Model | To construct the subcutaneous tumorigenesis model, the cells were suspended in 100 uL of PBS and Matrigel matrix (BD Biosciences, USA) (1:1) and injected into the right flanks of 6-week-old female BALB/c nude mice.To construct the lymph node metastasis model, we injected 1 × 105/50 uL stably infected SCC9 cells into the left hind footpads of BALB/c mice. | |||
Head and neck squamous carcinoma [ICD-11: 2B6E]
In total 2 item(s) under this disease | ||||
Experiment 1 Reporting the m6A-centered Disease Response | [1] | |||
Response Summary | METTL3 promotes Polycomb complex protein BMI-1 (BMI1) translation in OSCC under the cooperation with m6A reader IGF2BP1. And the study revealed that METTL3 promotes OSCC proliferation and metastasis through BMI1 m6A methylation. | |||
Responsed Disease | Oral squamous cell carcinoma [ICD-11: 2B6E.0] | |||
Target Regulator | Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2BP1) | READER | ||
Target Regulation | Up regulation | |||
In-vitro Model | UM1 | Tongue squamous cell carcinoma | Homo sapiens | CVCL_VH00 |
SCC-9 | Tongue squamous cell carcinoma | Homo sapiens | CVCL_1685 | |
SCC-25 | Tongue squamous cell carcinoma | Homo sapiens | CVCL_1682 | |
SCC-15 | Tongue squamous cell carcinoma | Homo sapiens | CVCL_1681 | |
HSC-3 | Tongue squamous cell carcinoma | Homo sapiens | CVCL_1288 | |
HOK | Normal | Hexagrammos otakii | CVCL_YE19 | |
In-vivo Model | To construct the subcutaneous tumorigenesis model, the cells were suspended in 100 uL of PBS and Matrigel matrix (BD Biosciences, USA) (1:1) and injected into the right flanks of 6-week-old female BALB/c nude mice.To construct the lymph node metastasis model, we injected 1 × 105/50 uL stably infected SCC9 cells into the left hind footpads of BALB/c mice. | |||
Experiment 2 Reporting the m6A-centered Disease Response | [1] | |||
Response Summary | METTL3 promotes Polycomb complex protein BMI-1 (BMI1) translation in OSCC under the cooperation with m6A reader IGF2BP1. And the study revealed that METTL3 promotes OSCC proliferation and metastasis through BMI1 m6A methylation. | |||
Responsed Disease | Oral squamous cell carcinoma [ICD-11: 2B6E.0] | |||
Target Regulator | Methyltransferase-like 3 (METTL3) | WRITER | ||
Target Regulation | Up regulation | |||
In-vitro Model | UM1 | Tongue squamous cell carcinoma | Homo sapiens | CVCL_VH00 |
SCC-9 | Tongue squamous cell carcinoma | Homo sapiens | CVCL_1685 | |
SCC-25 | Tongue squamous cell carcinoma | Homo sapiens | CVCL_1682 | |
SCC-15 | Tongue squamous cell carcinoma | Homo sapiens | CVCL_1681 | |
HSC-3 | Tongue squamous cell carcinoma | Homo sapiens | CVCL_1288 | |
HOK | Normal | Hexagrammos otakii | CVCL_YE19 | |
In-vivo Model | To construct the subcutaneous tumorigenesis model, the cells were suspended in 100 uL of PBS and Matrigel matrix (BD Biosciences, USA) (1:1) and injected into the right flanks of 6-week-old female BALB/c nude mice.To construct the lymph node metastasis model, we injected 1 × 105/50 uL stably infected SCC9 cells into the left hind footpads of BALB/c mice. | |||